Research on Multi-Actors' Interaction and Value Co-Creation Driven by Corporate Venture Capital from the Perspective of Symbiosis Theory

Authors

  • Yahui Zhang
  • Yuanqing Hao

DOI:

https://doi.org/10.62051/ijgem.v10n4.09

Keywords:

Symbiosis theory, Corporate venture capital, Multi-actors' interaction, Value co-creation

Abstract

Corporate venture capital is a window for incumbents to acquire new technologies, and it is also a key force to promote the growth of new ventures, the birth of unicorns and industrial innovation. Combined with the research status and development trend of CVC at home and abroad, the symbiotic unit, symbiotic relationship and symbiotic environment of symbiosis theory are embedded into the practice of corporate venture capital, aiming to build a multi-actors interaction mode driven by corporate venture capital. On this basis, the CVC driven multi-actors value co-creation integration system is built from the perspective of value creation, and the path selection of multi-actors value co-creation is proposed from the macro-level to create the "sensor + adapter" between the enterprise and the environment, the meso level to build the "channel" for the exchange of resources between enterprises, and the micro-level to improve the cognitive ability and creativity of individuals/teams. All these are to improve the ecological construction of equity investment market and promote the harmonious development of large and medium-sized enterprises.

Downloads

Download data is not yet available.

References

[1] Dushnitsky G, Lenox M L. When do firms undertake R&D by investing in new ventures? [J]. Strategic Management Journal, 2005(24): 947-965.

[2] Lin J Y. What affects new venture firm's innovation more in corporate venture capital? [J]. European Management Journal, 2020, 38(4): 646-660.

[3] Sarah Park, Joseph A. Li Puma, Sewon Sharon Park. Concentrating Too Hard? Foreign and Corporate Venture Capital Involvement in Syndicates [J]. Journal of Small Business Management, 2019, 57(2): 327-342.

[4] Ernst H, Witt P, Brachtendorf G. Corporate venture capital as strategy for external innovation: an exploratory empirical study [J]. R&D Management, 2005, 35(3): 233-243.

[5] Sahayma A, Steensmab H K, Barden J Q. The influence of R&D investment on the use of corporate venture capital: an industry-level analysis [J]. Journal of Business Venturing, 2010(25): 376-388.

[6] Basua S, Phelps C, Kotha S. Towards understanding who makes corporate venture capital investments and why [J]. Journal of Business Venturing, 2011(26): 153-171.

[7] Dokko G, Gaba V. Venturing into new territory: career experiences of corporate venture capital managers and practice variation [J]. Academy of Management Journal, 2012, 55(3): 563-583.

[8] Dushnitsky G, Shapira Z. Entrepreneurial finance meets organizational reality: Comparing investment practices and performance of corporate and independent venture capitalists [J]. Strategic Management Journal, 2010(31): 990-1017.

[9] Tong T W, Li Y. Real options and investment mode: evidence from corporate venture capital and acquisition [J]. Organization Science, 2011, 22(3): 659-674.

[10] Lee S M, Kim T, Jang S H. Inter-organizational knowledge transfer through corporate venture capital investment [J]. Management Decision, 2015, 53(7): 1601-1618.

[11] Wadhwa A, Phelps C, Kotha S. Corporate venture capital portfolios and firm innovation CVC [J]. Journal of Business Venturing, 2016(31): 95-112.

[12] Belderbos R, Jacob J, Lokshin B. Corporate venture capital (CVC) investments and technological performance: geographic diversity and the interplay with technology alliances CVC [J]. Journal of Business Venturing, 2018(33): 20-34.

[13] Varkey K. Titus Jr., Brian S. Anderson. Firm Structure and Environment as Contingencies to the Corporate Venture Capital--Parent Firm Value Relationship [J]. Entrepreneurship Theory and Practice, 2016(11): 1-25.

[14] Benson D, Ziedonis R H. Corporate Venture Capital as a Window on New Technologies: Implications for the Performance of Corporate Investors When Acquiring Startups [J]. Organization Science, 2009, 20(2): 329-351.

[15] Van de Vrande V, Vanhaverbeke W. How Prior Corporate Venture Capital Investments Shape Technological Alliances: A Real Options Approach [J]. Entrepreneurship Theory and Practice, 2012(4): 1-24.

[16] Pahnke E, Katila R, Eisenhardt K M. Eisenhardt. Who Takes You to the Dance? How Partners' Institutional Logics Influence Innovation in Young Firms [J]. Administrative Science Quarterly, 2015, 60(4): 596-633.

[17] Park H D, Steensma H K. When does corporate venture capital add value for new ventures? [J]. Strategic Management Journal, 2012(33): 1-22.

[18] Colombo M G, Shafi K. Swimming with sharks in Europe: When are they dangerous and what can new ventures do to defend themselves? [J]. Strategic Management Journal, 2016(37): 2307-2322.

[19] Di Lorenzo F, van de Vrande V. Tapping into the knowledge of incumbents: The role of corporate venture capital investments and inventor mobility [J]. Strategic Entrepreneurship Journal, 2019(13): 24-46.

[20] Maula M V J, Autio E, Murray G C. Corporate venture capital and the balance of risks and rewards for portfolio companies[J]. Journal of Business Venturing, 2009(24): 274-286.

[21] PARK H D, STEENSMA H K. The selection and nurturing effects of corporate investors on new venture innovativeness [J]. Strategic Entrepreneurship Journal, 2013(7): 311-330.

[22] Alvarez-Garrudo E, Dushnitsky G. Are entrepreneurial venture's innovation rates sensitive to investor complementary assets? Comparing biotech ventures backed by corporate and independent VCs [J]. Strategic Management Journal, 2016(37): 819-834.

[23] Park J H, Bae Z T. When are 'sharks' beneficial? Corporate venture capital investment and startup innovation performance [J]. Technology Analysis & Strategic Management, 2017, 30(3): 324-336.

[24] Paik Y, Woo H. The effects of corporate venture capital, founder incumbency, and their interaction on entrepreneurial firms' R&D investment strategy [J]. Organization Science, 2017, 28(4): 670-689.

[25] Wang X, Wan W P. Explaining the variance in underpricing among venture capital-backed IPOs: A comparison between private and corporate VC firms [J]. Strategic Entrepreneurship Journal, 2013(7): 331-342.

[26] Wang Susheng, Kang Yongbo, Peng Ke. Corporate Venture Capital (CVC), Real Options and Corporate Value Creation [J]. Management Review, 2017, 29(9): 110-121.

[27] Wan Kunyang, Lu Wencong. Corporate Venture Capital and Enterprise Technological Innovation: The Moderating Effects of Absorptive Capacity, Involvement Intensity and Governance Structure [J]. Science of Science and Management of S.& T., 35(11): 117-128.

[28] Wan Kunyang. The Influence Mechanism of Corporate Venture Capital on Enterprise Value Creation: Based on the Perspective of CVC Project Heterogeneity [J]. Industrial Technology & Economy, 2015(2): 27-33.

[29] Qiao Mingzhe, Zhang Yuli, Ling Yu, Li Jinliang. How Does Corporate Venture Capital Affect the IPO Underpricing of Venture Enterprises: Evidence from Shenzhen Growth Enterprise Market [J]. Nankai Business Review, 2017, 20(1): 167-180.

[30] Yuan Chunqing. Symbiosis Theory and Its Application Research on Small-scale Economy [J]. Reform, 1998(2): 101-105.

[31] Gutmann T, Schmeiss J, Stubner S. Unmasking smart capital: how corporate venture capital units configure value-adding services [J]. Research-Technology Management, 2019, 62(4): 27-36.

[32] Kim J Y, Steensma H K, Park H D. The influence of technological links, social ties, and incumbent firm opportunistic propensity on the formation of corporate venture capital deals [J]. Journal of Management, 2017, 43(5): 1609-1630.

[33] Dong Jing, Xu Wanyu. Corporate Venture Capital: "Interdependent Relationship" or "Dancing with Sharks"? Literature Review and Theoretical Construction [J]. Foreign Economics & Management, 2018, 40(2): 3-18.

[34] Lu Yao, Zhang Yeqing, Jia Rui, Li Jianhang. "Syndicated" Venture Capital and Enterprise Innovation [J]. Journal of Financial Research, 2017, 6(444): 159-175.

[35] Jiang Kaidong, Zhan Guobin. Research on Collaborative Innovation Models and Paths of Universities from the Perspective of Symbiosis Theory [J]. Science Research Management, 2020, 41(4): 123-130.

[36] Chen Chunhua, Zhao Hairan. Symbiosis: The Future Path of Organizational Evolution [M]. CITIC Publishing Group, Beijing: P007.

[37] Ceccagnoli M, Higgins M J, Kang H D. Corporate venture capital as a real option in the markets for technology [J]. Strategic Management Journal, 2018(39): 3355-3381.

[38] Hill S A, Birkinshaw J. Ambidexterity and survival in corporate venture units [J]. Journal of Management, 2014, 40(7): 1899-1931.

Downloads

Published

30-04-2026

Issue

Section

Articles

How to Cite

Zhang, Y., & Hao, Y. (2026). Research on Multi-Actors’ Interaction and Value Co-Creation Driven by Corporate Venture Capital from the Perspective of Symbiosis Theory. International Journal of Global Economics and Management, 10(4), 69-79. https://doi.org/10.62051/ijgem.v10n4.09